10/16/2026
New reports suggest the FDA may be preparing an interim enforcement discretion policy for certain peptides.
If adopted, it would allow compounding pharmacies to prepare these peptides before the FDA finishes its formal rulemaking process. Nothing has changed yet, and the peptides affected remain in a regulatory gray zone.
Read the full breakdown here: https://lengealaw.com/fda-peptide-interim-access-policy/